Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Apraclonidine in the treatment of ptosis
Subhashie Wijemanne
,
Dhanya Vijayakumar
, Joseph Jankovic
Research output
:
Contribution to journal
›
Article
›
peer-review
30
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Apraclonidine in the treatment of ptosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ptosis
100%
Apraclonidine
100%
Horner Syndrome
50%
Botulinum Neurotoxin (BoNT)
37%
Diagnostic Test
25%
Safe Treatment
12%
Receptor Agonist
12%
Effective Treatment
12%
Eyelid
12%
A1 Receptor
12%
Hydrochloride
12%
Ophthalmic Solutions
12%
Agonist Activity
12%
Botulinum Toxin Injection
12%
Levator Palpebrae Superioris
12%
Topical Ophthalmic
12%
Medicine and Dentistry
Ptosis
100%
Apraclonidine
100%
Horner's Syndrome
50%
Clostridium Botulinum Type A
50%
Diagnostic Test
25%
Receptor
12%
Levator Palpebrae Superioris Muscle
12%
Eyelid
12%
Pharmacology, Toxicology and Pharmaceutical Science
Apraclonidine
100%
Clostridium Botulinum Type A
66%
Horner's Syndrome
66%
Receptor Agonist
16%